Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Pozycja w akcjach #38575
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Cena akcji
$1.48
Kapitalizacja rynkowa
$883.58K
Zmiana (1 dzień)
-1.99%
Zmiana (1 rok)
-88.89%
Kraj
US
Handel Enveric Biosciences, Inc. (ENVB)

Kategoria

Historia stopy dywidendy dla Enveric Biosciences, Inc. (ENVB)
Stopa dywidendy (TTM) dla Enveric Biosciences, Inc. (symbol akcji: ENVB) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Enveric Biosciences, Inc. (ENVB) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji